Structure-activity relationships leading to WAY-121,520, a tris aryl-type, indomethacin-based, phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitor.

A Kreft; J Nelson; J Musser; A Failli; U Shah; D Kubrak; A Banker; R Steffan; G Schiehser; R Sturm

doi:10.1007/BF01972712

Structure-activity relationships leading to WAY-121,520, a tris aryl-type, indomethacin-based, phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitor.

Identifier:nobleid.org/w1/20260515/98BBA29F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/98BBA29F.svg?ark=w1%2F20260515%2F98BBA29F)](https://nobleid.org/work/w1/20260515/98BBA29F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Structure-activity relationships leading to WAY-121,520, a tris aryl-type, indomethacin-based, phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitor.

Identifier:nobleid.org/w1/20260515/98BBA29F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/98BBA29F.svg?ark=w1%2F20260515%2F98BBA29F)](https://nobleid.org/work/w1/20260515/98BBA29F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work